Association of Jagged1 expression with malignancy and prognosis in human pancreatic cancer
Jungwhoi Lee(Korea Advanced Institute of Science and Technology), Jae‐Hoon Kim(Bio-Medical Science (South Korea))
Cited by 24
Related Papers
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
|The Lancet Oncology|2021|412
Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro
|PLoS ONE|2016|160
Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation.
|Journal of Clinical Oncology|2020|110